Kmiecik, S.W.; Lewis, J.; Schwickert, J.; Breitenreicher, H.; Sprick, M.R.; Burhenne, J.
Validation of a UPLC-MS/MS Method for Quantifying Intracellular Olaparib Levels in Resistant Ovarian Cancer Cells. Pharmaceuticals 2025, 18, 1870.
https://doi.org/10.3390/ph18121870
AMA Style
Kmiecik SW, Lewis J, Schwickert J, Breitenreicher H, Sprick MR, Burhenne J.
Validation of a UPLC-MS/MS Method for Quantifying Intracellular Olaparib Levels in Resistant Ovarian Cancer Cells. Pharmaceuticals. 2025; 18(12):1870.
https://doi.org/10.3390/ph18121870
Chicago/Turabian Style
Kmiecik, Szymon W., Jennifer Lewis, Jonas Schwickert, Henrik Breitenreicher, Martin R. Sprick, and Jürgen Burhenne.
2025. "Validation of a UPLC-MS/MS Method for Quantifying Intracellular Olaparib Levels in Resistant Ovarian Cancer Cells" Pharmaceuticals 18, no. 12: 1870.
https://doi.org/10.3390/ph18121870
APA Style
Kmiecik, S. W., Lewis, J., Schwickert, J., Breitenreicher, H., Sprick, M. R., & Burhenne, J.
(2025). Validation of a UPLC-MS/MS Method for Quantifying Intracellular Olaparib Levels in Resistant Ovarian Cancer Cells. Pharmaceuticals, 18(12), 1870.
https://doi.org/10.3390/ph18121870